Ro vs SkinnyRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
SkinnyRx beats Ro overall, scoring 7.3/10 vs 7.2/10. Ro is more affordable at $149/mo vs $199/mo. Choose Ro for users who want fda-approved brand-name glp-1 access includin. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.
A side-by-side look at Ro and SkinnyRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Ro
#43 of 53One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit RoSkinnyRx
#35 of 53Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats, injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only, does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.
Visit SkinnyRx| Feature | Ro | SkinnyRx |
|---|---|---|
| Our Score | 7.2/10 | 7.3/10 |
| Starting Price | $149/mo | $199/mo |
| Medication Type | Brand | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing | Users who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point |
| Watch out for | Membership and medication are billed separately, readers need to add them together for the all-in monthly cost | No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere |
| Ranking | #43 | #35 |
| Get started | Visit Ro | Visit SkinnyRx |
Pros & Cons Compared
Ro
Pros
- +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-299/mo via LillyDirect matching
- +Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
- −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
SkinnyRx
Pros
- +Five medication formats, the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
- +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
- +Fast onboarding: 5-10 minute online questionnaire, physician review in 24-48 hours, medication delivered in 3-7 business days with temperature-controlled shipping
- +4,100+ Trustpilot reviews at 4.8 stars, among the strongest aggregate social-proof signals in the GLP-1 telehealth category
Cons
- −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere
- −Light public disclosure: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site, ask support before enrolling if provenance matters to you
- −Cash-pay only, does not bill commercial insurance, Medicare, or Medicaid. HSA/FSA payments are accepted, which is the main way to soften the cost.
- −Independent reviews flag inconsistent customer-service responsiveness, a real consideration since titration support and dose adjustments run through chat
Our Verdict
SkinnyRx edges out Ro with a score of 7.3/10 vs 7.2/10. If budget is your priority, Ro starts at $149/mo compared to SkinnyRx's $199/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.
Read Full Reviews
Related comparisons
Other matchups readers comparing Ro or SkinnyRx tend to look at next.
- Ro vs Found$129/mo
- Ro vs GoodRx Care$119/mo
- Ro vs Fella Health$299/mo
- SkinnyRx vs Bodybuilding Health+$179/mo
- SkinnyRx vs TrimRx$149/mo
- SkinnyRx vs Maximus$150/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.